...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: More Exempt Distribution Investments

The date of the Distribution.....when the funds will take place. (Jan 11, 2024)

 

Koo

Share
New Message
Please login to post a reply